Intercept Wants More Time to Address EMA’s Questions Over Its NASH Treatment

EU Review Of Obeticholic Acid Began Around 18 Months Ago

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".